- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02542540
Effects of a Physical Rehabilitation Program Using the Nintendo Wii on Children With Osteogenesis Imperfecta (OI)
Effects of a Physical Rehabilitation Program Using the Nintendo Wii on Children With Osteogenesis Imperfecta (OI) Is Nintendo Wii an Effective Intervention for Children With Osteogenesis Imperfecta
Children with osteogenesis imperfecta are described as extremely sedentary and therefore fatigable, which strongly impacts their daily activities. The physical rehabilitation of these children is a fundamental aspect of treatment.
It has been shown that playing Wii console causes the same increase in energy expenditure than practicing moderate exercise, while ensuring user safety. This type of physical exercise with this type of fun game console might have a role in the treatment of OI children on the physical side but also on the psychological side.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Saint-Etienne, France, 42055
- Chu Saint-Etienne
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- - Children affiliated to a social security scheme
- Children diagnosed OI by a competent physician of one of the French specialist centers;
- OI children type 1 or type 4;
- Stable OI (far from a fractional episode of at least two months);
- Children without regular activity on the Nintendo Wii console or other interactive console;
- Boy or Girl> 6 to 18 years
- Parents or person having parental authority affiliated to a social security scheme
- Parents or person having parental authority who signed the consent form for the study.
Exclusion Criteria:
- - Children who can not walk;
- Children with severe OI other than type 1 or type 4;
- Fracture during the last two months;
- Surgical intervention within the last 8 months;
- Inability to understand and follow the protocol;
- Participation in another clinical study;
- Children, parents or holder of parental authority refusing the written consent.
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: OI Children training with Nintendo Wii console
Training for 3 months using the Nintendo Wii console on physical capacity in a group of children with Osteogenesis Imperfecta
|
Children with OI and draining for 3 months using Nintendo Wii console
|
No Intervention: Children with OI without training
No training
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in physical capacity
Time Frame: from baseline to 3 months
|
Compare the change in physical capacity between training group of children with OI and control group of children with OI.
The physical capacity is measured by maximal oxygen consumption VO2 max (ml/min/kg) measured during incremental exercise on cycle ergometer
|
from baseline to 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in physical capacity
Time Frame: From baseline to 9 months
|
Compare the change in physical capacity between training group of children with OI and control group of children with OI.
The physical capacity is measured by maximal oxygen consumption VO2 max (ml/min/kg) measured during incremental exercise on cycle ergometer
|
From baseline to 9 months
|
Compare physical inactivity between training group and control group
Time Frame: Month 3
|
Physical inactivity will be assessed by the Physical Activity Questionnaire (Q-APS)
|
Month 3
|
Compare physical inactivity between training group and control group
Time Frame: Month 9
|
Physical inactivity will be assessed by the Physical Activity Questionnaire (Q-APS)
|
Month 9
|
Compare functional benefit between training group and control group
Time Frame: Month 3
|
The functional benefit will be evaluated by the Functional Independence Measure (FIM)
|
Month 3
|
Compare functional benefit between training group and control group
Time Frame: Month 9
|
The functional benefit will be evaluated by the Functional Independence Measure (FIM)
|
Month 9
|
Compare body fat between training group and control group
Time Frame: Month 3
|
Body fat composition will be determined by skinfold measurements
|
Month 3
|
Compare body fat between training group and control group
Time Frame: Month 9
|
Body fat composition will be determined by skinfold measurements
|
Month 9
|
Compare quality of life between training group and control group
Time Frame: Month 3
|
The quality of life will be determined the Index Questionnaire Reintegration to Normal Life (IRVN)
|
Month 3
|
Compare quality of life between training group and control group
Time Frame: Month 9
|
The quality of life will be determined the Index Questionnaire Reintegration to Normal Life (IRVN)
|
Month 9
|
Compare muscle strength between training group and control group
Time Frame: Month 3
|
The muscle strength is a composite outcome. It will be assessed by:
|
Month 3
|
Compare muscle strength between training group and control group
Time Frame: Month 9
|
The muscle strength is a composite outcome. It will be assessed by:
|
Month 9
|
Compare endurance of lower limbs between training group and control group
Time Frame: Month 3
|
The endurance of the lower limbs will be measured by EMG analysis on incremental torque repetitive exercise
|
Month 3
|
Compare endurance of lower limbs between training group and control group
Time Frame: Month 9
|
The endurance of the lower limbs will be measured by EMG analysis on incremental torque repetitive exercise
|
Month 9
|
Compare Energy expenditure of lower limbs between training group and control group
Time Frame: Month 3
|
Energy expenditure is a composite outcome.
It will be measured by collecting the respiratory exchange and heart rate during endurance, tennis and boxing games using the Nintendo WII
|
Month 3
|
Compare Energy expenditure of lower limbs between training group and control group
Time Frame: Month 9
|
Energy expenditure is a composite outcome.
It will be measured by collecting the respiratory exchange and heart rate during endurance, tennis and boxing games using the Nintendo WII
|
Month 9
|
Training tolerance
Time Frame: Baseline from 9 months
|
Reentrainment tolerance is a composite outcome. It will be assessed by :
|
Baseline from 9 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Vincent GAUTHERON, PhD, Chu Saint-Etienne
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1201174
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteogenesis Imperfecta
-
Nationwide Children's HospitalCompletedOsteogenesis Imperfecta Type III | Osteogenesis Imperfecta Type IIUnited States
-
Ultragenyx Pharmaceutical IncMereo BioPharmaCompletedOsteogenesis Imperfecta Type III | Osteogenesis Imperfecta Type IV | Osteogenesis Imperfecta, Type IUnited States, Canada, Denmark, France, United Kingdom
-
Emory UniversityNot yet recruitingOsteogenesis Imperfecta | Osteogenesis Imperfecta Type III
-
Novartis PharmaceuticalsCompletedOsteogenesis ImperfectaUnited States
-
Shriners Hospitals for ChildrenNovartisCompleted
-
AmgenTerminatedOsteogenesis Imperfecta (OI)Canada, Czechia, Spain, United Kingdom, United States, Italy, Hungary, Australia, Belgium, France, Germany, Poland
-
Istituto Ortopedico RizzoliRecruitingOsteogenesis ImperfectaItaly
-
Baylor College of MedicineRecruiting
-
SanofiRecruitingOsteogenesis ImperfectaUnited States, Australia, Canada, France
-
Ultragenyx Pharmaceutical IncMereo BioPharmaRecruitingOsteogenesis ImperfectaUnited States, Canada, Turkey, Argentina, Germany, Australia, Italy, Portugal, United Kingdom, Poland, France, Netherlands
Clinical Trials on Training with Nintendo Wii console
-
Queen's UniversityWalmartCompletedChronic SchizophreniaCanada
-
Sao Camilo University CenterCompleted
-
Örebro County CouncilNorrbacka-Eugenia Foundation; Uppsala-Örebro Regional Research CouncilCompletedMultiple SclerosisSweden
-
University of Missouri-ColumbiaWithdrawnDistorted; BalanceUnited States
-
Aalborg University HospitalCompleted
-
Federal University of BahiaCompletedParkinson DiseaseBrazil
-
Federal University of BahiaCompletedParkinson DiseaseBrazil
-
University Health Network, TorontoTerminatedVestibular Diseases | Disturbance; Balance, LabyrinthCanada
-
University of BaselPsychiatric Hospital of the University of Basel; University Children's Hospital...UnknownDepression | Quality of Life | Sleep | Crohn Disease | Ulcerative Colitis | Motor ActivitySwitzerland
-
Cairo UniversityRecruiting